Rheumatoid arthritis trials recruiting in New York

All Rheumatoid arthritis trials nationally

Cities in New York

Recruiting trials in New York

• A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
  NCT06733935 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: New York, Stony Brook, Syracuse
• A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
  NCT06570798 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: Great Neck, Hawthorne, New York, Rochester
• A Study of AZD0120 in Autoimmune Diseases
  NCT07295847 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: New York
• A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
  NCT07412704 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
  NCT07041099 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New York: Brooklyn
• A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
  NCT07137598 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: The Bronx
• A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
  NCT06972446 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: Great Neck
• Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis
  NCT05782335 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
  NCT01776398 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumatologist Care: A Randomized Controlled Trial
  NCT07034196 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Potsdam
• ConsideRAte Study - Splenic Stimulation for RA
  NCT05003310 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 75 Years · Sex: All (male and female) · New York: Brooklyn
• Exactech Shoulder Post Market Clinical Follow-up Study
  NCT05603728 · Phase: Not specified · Ages: 21 Years and older · Sex: All (male and female) · New York: New York
• Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being
  NCT07222696 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)
  NCT05197530 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New York: Rochester
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
  NCT07138898 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
  NCT02418442 · Phase: Not specified · Ages: Up to 21 Years · Sex: All (male and female) · New York: Albany, Lake Success, New York, Rochester
• Physica System Total Knee Replacement Registry Study
  NCT03048201 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: All (male and female) · New York: Syracuse
• RA-PRO PRAGMATIC TRIAL
  NCT04692493 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New York: Mineola, New York